Platelet function testing in hirudin and BAPA anticoagulated blood

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 3, 2011, Pages 501-507

  Mani, Helen ^a   Hellis, Mirna ^a   Lindhoff Last, Edelgard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

benzylsulfonyl d Arg Pro 4 amidinobenzy lamide (BAPA); citrate; hirudin; platelet function tests; vasodilator stimulated phosphoprotein (VASP) assay

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BENZYLSULFONYL DEXTRO ARGININE PROLINE 4 AMIDINOBENZYLAMIDE; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; HIRUDIN; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

ADENOSINE DIPHOSPHATE; ADULT; AGED; ARACHIDONIC ACID; BLOOD PLATELETS; DIPEPTIDES; FEMALE; HIRUDINS; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; SULFONAMIDES;

EID: 79952813646     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.074     Document Type: Article

References (27)

1. Harrison P, Path FR, Mumford A. Screening tests of platelet function: Update on their appropriate use for diagnostic testing. Semin Thromb Hemost 2009;35:150-7.
2. Rocca B, Patrono C. Determinants of the interindividual variability in response to antiplatelet drugs. J Thromb Haemost 2005;3:1597-602. (Pubitemid 41716544)
3. Pulcinelli FM, Riondino S. More on aspirin resistance: Position paper of the Working Group on Aspirin Resistance. Proposal for the laboratory test-guiding algorithm. J Thromb Haemost 2006; 4:485-7.
4. Packham MA, Bryant NL, Guccione MA, Kinlough-Rathbone RL, Mustard JF. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Thromb Haemost 1989;62:968-76. (Pubitemid 20005012)
5. Storey RF, Wilcox RG, Heptinstall S. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation 1998;98:1616-21. (Pubitemid 28500383)
6. Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: A report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009;7:1029.
7. Christie DJ, Avari T, Carrington LR, Cohen E, DeBiase BA, Harrison P, et al. Platelet function testing by aggregometry; approved guideline. Clinical and Laboratory Standards Institute, Wayne, PA, USA 2008; Vol. 28 No. 31, available on-line at www.clsi.org.
8. Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Haemost 1991;66:141-52.
9. Hellstern P, Stürzebecher U, Wuchold B, Haubelt H, Seyfert UT, Bauer M, et al. Preservation of in vitro function of platelets stored in the presence of a synthetic dual inhibitor of factor Xa and thrombin. J Thromb Haemost 2007;5:2119-26. (Pubitemid 47450032)
10. Mani H, Kirchmayr K, Kläffling C, Schindewolf M, Luxembourg B, Linnemann B, et al. Influence of blood collection techniques on platelet function. Platelets 2004;15:315-8. (Pubitemid 39037133)
11. Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: An adjustment for platelet count is not necessary. J Thromb Haemost 2008;6:677-83. (Pubitemid 351404936)
12. Mani H, Luxembourg B, Kläffling C, Erbe M, Lindhoff-Last E. Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements. J Clin Pathol 2005;58: 747-50. (Pubitemid 40956832)
13. Mani H, Linnemann B, Luxembourg B, Kirchmayr K, Lindhoff-Last E. Response to aspirin and clopidogrel monitored with different platelet function methods. Platelets 2006;17: 303-10. (Pubitemid 44277696)
14. Linnemann B, Prochnow S, Mani H, Schwonberg J, Lindhoff-Last E. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term followup. Ann Hematol 2009;88:979-88.
15. Tóth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-8. (Pubitemid 44883819)
16. Mueller T, Dieplinger B, Poelz W, Calatzis A, Haltmayer M. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel multiplate analyzer - comparison with two flow cytometric methods. Thromb Res 2007;121:249-58. (Pubitemid 350148206)
17. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-6.
18. van Werkum JW, van der Stelt CA, Seesing TH, ten Berg JM, Hackeng CM. The flow cytometric VASP assay can be used to determine the effectiveness of clopidogrel in patients treated with abciximab. J Thromb Haemost 2007;5:881-3. (Pubitemid 46563598)
19. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005;3: 85-92. (Pubitemid 41647119)
20. Schwarz UR, Geiger J, Walter U, Eigenthaler M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - definition and detection of ticlopidine/ clopidogrel effects. Thromb Haemost 1999;82:1145-52. (Pubitemid 29419734)
21. Haubelt H, Vogt A, Hellstern P. Preservation of platelet aggregation and dense granule secretion during extended storage of blood samples in the presence of a synthetic dual inhibitor of factor Xa and thrombin. Platelets 2008;19:496-501.
22. Wallén NH, Ladjevardi M, Albert J, Bröijersén A. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Thromb Res 1997;87:151-7. (Pubitemid 27333272)
23. Kalb ML, Potura L, Scharbert G, Kozek-Langenecker SA. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets 2009;20:7-11.
24. Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, et al. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2010;103:151-9.
25. Halimeh S, Angelis G, Sander A, Edelbusch C, Rott H, Thedieck S, et al. Multiplate whole blood impedance point of care aggregometry: Preliminary reference values in healthy infants, children and adolescents. Klin Padiatr 2010;222:158-63.
26. Pittens CA, Bouman HJ, van Werkum JW, Ten Berg JM, Hackeng CM. Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests. J Thromb Haemost 2009;7: 1929-32.
27. Truss NJ, Armstrong CJ, Liverani E, Vojnovic I, Warner TD. Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods. J Thromb Haemost 2009;7: 1897-905.